Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock

St Paul's Hospital, iCAPTURE Centre, Canada.
Critical care medicine (Impact Factor: 6.15). 04/2009; 37(3):811-8. DOI: 10.1097/CCM.0b013e3181961ace
Source: PubMed

ABSTRACT Vasopressin and corticosteroids are often added to support cardiovascular dysfunction in patients who have septic shock that is nonresponsive to fluid resuscitation and norepinephrine infusion. However, it is unknown whether vasopressin treatment interacts with corticosteroid treatment.
Post hoc substudy of a multicenter randomized blinded controlled trial of vasopressin vs. norepinephrine in septic shock.
Twenty-seven Intensive Care Units in Canada, Australia, and the United States.
: Seven hundred and seventy-nine patients who had septic shock and were ongoing hypotension requiring at least 5 microg/min of norepinephrine infusion for 6 hours.
Patients were randomized to blinded vasopressin (0.01-0.03 units/min) or norepinephrine (5-15 microg/min) infusion added to open-label vasopressors. Corticosteroids were given according to clinical judgment at any time in the 28-day postrandomization period.
The primary end point was 28-day mortality. We tested for interaction between vasopressin treatment and corticosteroid treatment using logistic regression. Secondary end points were organ dysfunction, use of open-label vasopressors and vasopressin levels.
There was a statistically significant interaction between vasopressin infusion and corticosteroid treatment (p = 0.008). In patients who had septic shock and were also treated with corticosteroids, vasopressin, compared to norepinephrine, was associated with significantly decreased mortality (35.9% vs. 44.7%, respectively, p = 0.03). In contrast, in patients who did not receive corticosteroids, vasopressin was associated with increased mortality compared with norepinephrine (33.7% vs. 21.3%, respectively, p = 0.06). In patients who received vasopressin infusion, use of corticosteroids significantly increased plasma vasopressin levels by 33% at 6 hours (p = 0.006) to 67% at 24 hours (p = 0.025) compared with patients who did not receive corticosteroids.
There is a statistically significant interaction between vasopressin and corticosteroids. The combination of low-dose vasopressin and corticosteroids was associated with decreased mortality and organ dysfunction compared with norepinephrine and corticosteroids.

Download full-text


Available from: John Granton, Jul 27, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Continual updating of estimates required by most recursive estimation schemes often involves redundant usage of information and may result in system instabilities in the presence of bounded output disturbances. This paper investigates an algorithm which has the capability of eliminating these difficulties. Based on a set theoretic assumption, the algorithm yields modified least-squares estimates with a forgetting factor. It updates the estimates selectively depending on whether the observed data contain sufficient information. The information evaluation required at each step involves very simple computations. In addition, the parameter estimates are shown to converge asymptotically to a region around the true parameter at an exponential rate.
    Decision and Control, 1985 24th IEEE Conference on; 01/1986
  • [Show abstract] [Hide abstract]
    ABSTRACT: An example from the cardiac pacemaker industry of safety-orientated software-design methodology is provided. Safety consideration begins upon product description with a hazard analysis whereby potential hazards are classified according to their criticality and rough probability of occurrence. The completed hazard analysis determines the software safety requirements which specify what the system will not do. A system-hazard cross-check matrix is defined that serves to direct the design team to those areas requiring more scrutiny. Traceability matrices provide a verifiable link from safety requirements design to the actual code. This methodology should serve to minimize hazards in the final software product
    Engineering of Computer-Based Medical Systems, 1988., Proceedings of the Symposium on the; 07/1988
  • [Show abstract] [Hide abstract]
    ABSTRACT: The authors describe a video broadcasting trial carried out at frequencies in the 12-GHZ band by GEC Plessey Telecommunications in collaboration with Marconi Defence Systems Ltd. over a 10-week trial period from December 1988 to February 1989. Details of equipment configurations and trial parameters are presented, together with an analysis of the measured data and the conclusions drawn. A broadcast model developed by the GEC-Marconi Research Centre was used to predict the coverage area. The trial clearly indicated that frequencies around 12 GHz are eminently suitable for TV broadcasting from terrestrial transmitters using frequency modulation
    Communications, 1990. ICC '90, Including Supercomm Technical Sessions. SUPERCOMM/ICC '90. Conference Record., IEEE International Conference on; 05/1990
Show more